TRAZODONE

67. Litovitz TL, Normann SA & Veltri JC: 1985 Annual Report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1986; 4:427-458.
68. Lovett LJ, Nygard GA, Khalil SKW: A simple HPLC method for the determination of trazodone in human serum. J Liq Chromatog 1987; 10:909-919.
69. Maguire J & Singh AN: Allergic type response to trazodone (letter). Br J Psychiatr 1987; 150:271-272.
70. Martin A & Pounder DJ: Post-mortem toxico-kinetics of trazodone. Forensic Science International 1992; 56(2):201-207.
71. Mills KC: Serotonin syndrome: a clinical update. Med Toxicol 1997; 13:763-783.
72. Patel HC, Bruza D & Yeragani V: Myoclonus with trazodone (letter). J Clin Psychopharmacol 1988; 8:152.
73. Patterson BD & Srisopark MM: Severe anorexia and possible psychosis or hypomania after trazodone-tryptophan treatment of aggression. Lancet 1989; 1:1017.
74. Pellettier JR & Bartolucci G: Trazodone and cardiovascular side effects. J Clin Psychopharmacol 1984; 4:119.
75. Personal Communication: Carolyn E. Reisinger, Mead Johnson Pharmaceutical, Evansville, IN, March 16, 1987.
76. Pescatori ES, Engelman JC, Davis G et al: Priapism of the clitoris: a case report following trazodone use. J Urology 1993; 149:1557-1559.
77. Product Information Ativan(R), 1999, Wyeth-Ayerst Co, Philadelphia, PA
78. Product Information: Ativan(R), lorazepam. Wyeth, Philadelphia, PA, 1991.
79. Product Information: Desyrel(R), trazodone, Mead Johnson, 1982.
80. Putzolu S, Pecknold JC, Baiocchi L et al: Trazodone: Clinical and biochemical studies, II. Blood levels and therapeutic responsiveness. Psychopharmacol Bull 1976; 12:40-41.
81. Rausch JL, Pavlinac DM & Newman PE: Complete heart block following a single dose of trazodone. Am J Psychiatry 1984; 141:1472-1473.
82. Rawls WN: Trazodone. Drug Intell Clin Pharm 1982; 16:7-13.
83. Root I & Ohlson GB: Trazodone overdose: report of two cases. J Anal Toxicol 1984; 8:91-94.
84. Rosen P: Emergency Medicine, 2nd Ed, CV Mosby Company, St Louis, MO, 1988.
85. RTECS: Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health, Cincinnati, Ohio (Internet Version). Micromedex, Inc., Englewood, CO, 2000.
86. Scott R, Besag FMC, Neville BGR: Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomized trial. Lancet 1999; 353:623-626.
87. Shoemaker WC, Ayers S, Grenvik A et al: Textbook of Critical Care, 2nd Ed, WB Saunders Company, Philadelphia, PA, 1989.
88. Smith WM & Gallagher JJ: "Les torsades de pointes": an unusual ventricular arrhythmia. Ann Intern Med 1980; 93:578-584.
89. Spivak B, Radvan, M, Shine M: Postural hypotension with syncope possibly precipitated by trazodone. Am J Psychiatr 1987; 144:1512-1513.
90. Sternbach H: The serotonin syndrome. Am J Psychiatr 1992; 149:1410-1411.
91. Sweetman S (Ed): Martindale: The Complete Drug Reference. London: Pharmaceutical Press, (Electronic Version). Micromedex, Inc, Englewood, CO, 2000.
92. Tasini M: Complex partial seizures in a patient receiving trazodone. J Clin Psychiatry 1986; 47:318-319.
93. Taylor DP, Hyslop DK & Riblet LA: Trazodone, a new nontricyclic antidepressant without anticholinergic activity. Biochem Pharmacol 1980; 29:2149-2150.
94. Tibbles PM, Burns MJ, Spencer FA et al: Trazodone cardiotoxicity following overdose. J Tox-Clin Tox 1997; 35:499.
95. Tzivoni D, Banai S, Schuger C et al: Treatment of torsade de pointes with magnesium sulfate. Circulation 1988; 77:392-397.
96. USP DI Volume I Drug information for the health care professional. 20th edition, 2000; Micromedex Inc, World Color Book Services, Taunton, MA.
97. Vale JA: Position Statement: gastric lavage. American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Clin Toxicol 1997; 35:711-719.
98. Van de Merwe, Silverstone T & Ankier SI: Electrophysiological and haemodynamic changes with trazodone, amitriptyline and placebo in depressed out-patients. Curr Med Res Opin 1984; 9:339-352.
99. Van der Klauw MM, Janssen JC & Stricker BH: Agranulocytosis probably induced by trazodone (letter). Am J Psychiatry 1993; 150(10):1563-1564.
100. Van Zwieten PA: Inhibition of the central hypotensive effect of clonidine by trazodone: A novel antidepressant. Pharmacology 1977; 15:331-336.
101. Vanpee D, Laloyaux P, Gillet JB et al: Seizure and hyponatraemia after overdose of trazadone (letter). Am J Emerg Med 1999; 17:430-431.
102. Vitullo RN, Wharton JM, Allen NB et al: Trazodone-related exercise-induced nonsustained ventricular tachycardia. Chest 1990; 98:247-248.
103. Vlay SC & Friedling S: Trazodone exacerbation of VT. Am Heart J 1983; 106:604.
104. Warren M & Bick PA: Two case reports of trazodone-induced mania. Am J Psychiatry 1984; 141:1103-1104.
105. Wedin GP, Oderda GM, Klein-Schwartz W et al: Relative toxicity of cyclic antidepressants. Ann Emerg Med 1985; 15:797-804.
106. Wittebole X, Jacquet L, Wallemacq P et al: Trazodone poisoning with Torsades de Pointe and prolonged need for inotropic support (abstract). EAPCCT XX International Congress, May 2-5, 2000; Amsterdam, The Netherlands.
107. Wong HY, Waugh SW, Draz M et al: Liquid-chromatographic determination of two antidepressants, trazodone and mianserin, in plasma. Clin Chem 1984; 30:230-233.
108. Zmitek A: Trazodone-induced mania (letter). Br J Psychiatry 1987; 151:274-275.

13.0 AUTHOR INFORMATION

13.1 CONTRIBUTOR(S) TO THIS DOCUMENT

A. Original publication: 12/86
B. Most recent revision: 11/00
C. List of contributors:

§ 1. Paul Kolecki, MD

§ 2. Walter Buylaert, MD (Belgium)

§ 3. Andrew Heath, MD, PhD (Sweden)

§ 4. Margaret M McCarron, MD

§ 5. David J George, PhD

§ 6. W Buylaert, MD (Belgium)

§ 7. Ken Kulig, MD

§ 8. POISINDEX(R) Editorial Staff

D. Specialty Board: CNS DRUGS

Refer to the POISINDEX EDITORIAL BOARD section for more information. (MG0579)

End of Document